noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Healthcare

Viridian Therapeutics Inc.

11/15/2021 | Press release | Distributed by Public on 11/15/2021 06:06

Viridian Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for VRDN-001, an IGF-1R Antibody for the Treatment of Thyroid Eye Disease (TED)

Sharing and Personal Tools

Please select the service you want to use:

Smartlinks | Viridian Therapeutics Inc. | News | Health | Healthcare Policy | Science | Biology | Research | Local News | Politics and Policy | Healthcare Policy | Policy and Regulation | Business and Economy | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Top Company News | Issue of Shares and Capital Increase | Business Announcement | Products and Services | Corporate Litigation and Regulation | Public Share Offering | Pharmaceuticals | Public Companies | Biotechnology and Medical Research Companies | London Stock Exchange (LSE) | Börse Frankfurt | Börse Berlin | Börse Stuttgart | Tradegate Exchange | NYSE American | NYSE ARCA Equities | Nasdaq Capital Market | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | FINRA Alternative Display Facility (ADF) | NYSE Chicago

Back

Download the original document